|
WWTR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.38130001775738E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.51760004141988E-09 |
| Normal-vs-Stage2 |
1.84609999999141E-05 |
| Normal-vs-Stage3 |
1.54379997674425E-09 |
| Normal-vs-Stage4 |
1.9476997792367E-10 |
| Stage1-vs-Stage2 |
3.281200E-01 |
| Stage1-vs-Stage3 |
2.293400E-01 |
| Stage1-vs-Stage4 |
3.458100E-02 |
| Stage2-vs-Stage3 |
1.006760E-01 |
| Stage2-vs-Stage4 |
3.074500E-02 |
| Stage3-vs-Stage4 |
3.948800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.49289979956802E-10 |
| Normal-vs-AfricanAmerican |
9.753100E-04 |
| Normal-vs-Asian |
2.17950000003242E-06 |
| Caucasian-vs-AfricanAmerican |
2.601700E-02 |
| Caucasian-vs-Asian |
1.373790E-01 |
| AfricanAmerican-vs-Asian |
3.756200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.43980005274625E-10 |
| Normal-vs-Female |
8.41900005266183E-09 |
| Male-vs-Female |
1.651560E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.89950000173411E-08 |
| Normal-vs-Age(41-60Yrs) |
2.96510005437511E-09 |
| Normal-vs-Age(61-80Yrs) |
2.4870999704163E-09 |
| Normal-vs-Age(81-100Yrs) |
9.759600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.230600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.375600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.689200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.966400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.949200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.594600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.592200E-04 |
| Classical-VS-Follicular |
6.288800E-01 |
| Classical-VS-Other |
1.693600E-01 |
| Classical-VS-Normal |
2.02369999646734E-08 |
| Tall-VS-Follicular |
1.537440E-03 |
| Tall-VS-Other |
9.625200E-01 |
| Tall-VS-Normal |
1.96089811055344E-11 |
| Follicular-VS-Other |
1.531950E-01 |
| Follicular-VS-Normal |
2.71660000050744E-07 |
| Other-VS-Normal |
2.61130000001053E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.336800028097E-09 |
| Normal-vs-N1 |
3.87279985858413E-10 |
| N0-vs-N1 |
1.090180E-01 |
|
|
